Perfluoroalkyl acids (PFAAs), specifically perfluorinated sulfonates and carboxylates, are synthetic substances known for their chemical stability, resistance to degradation, and potential to biomagnify in food chains. The toxicological and biological effects of PFAAs in avian species are not well characterized, although there is some evidence to suggest that they can impact neurodevelopment and hatching success. Our laboratory recently reported significant effects of perfluorohexane sulfonate (PFHxS) and perfluorohexanoate (PFHxA) on messenger RNA (mRNA) levels of thyroid hormone (TH)-responsive genes in chicken embryonic neuronal cells. In this study, we determined in ovo effects of PFHxS and PFHxA exposure (maximum dose 5 38,000 and 9700 ng/g egg, respectively) on embryonic death, developmental endpoints, tissue accumulation, mRNA expression in liver and cerebral cortex, and plasma TH levels. Pipping success was reduced to 63% at the highest dose of PFHxS; no effects were observed for PFHxA. PFHxS exposure (38,000 ng/g) decreased tarsus length and embryo mass. PFHxS and PFHxA accumulated in the three tissue compartments analyzed as follows: yolk sac > liver > cerebral cortex. Type II and type III 5#-deiodinases (D2 and D3) and cytochrome P450 3A37 mRNA levels were induced in liver tissue of chicken embryos exposed to PFHxS, whereas D2, neurogranin (RC3), and octamer motif binding factor 1 mRNA levels were upregulated in cerebral cortex. Plasma TH levels were reduced in a concentration-dependent manner following PFHxS exposure; PFHxA had no effect. This in ovo study successfully validated previous in vitro results concerning the modulation of TH-responsive genes and identified adverse effects associated with TH homeostasis in response to PFHxS treatment.
Perfluoroalkyl acids (PFAAs), specifically perfluorinated sulfonates (PFSAs) and carboxylates (PFCAs), are a family of man-made, fluorinated organic compounds used as surfactants and water and stain repellents in carpets, paper, and textiles (NTP, 2011) . PFAAs are resistant to biodegradation and persistent in the environment (Lau et al., 2004) . Trophodynamic studies have demonstrated that PFSAs and PFCAs have the potential to bioaccumulate and biomagnify in the food chain, ultimately leading to their detection in wildlife occupying high trophic positions and humans worldwide (Giesy and Kannan, 2001; Houde et al., 2011; Tomy et al., 2009; Yeung et al., 2009) . In wild avian populations, PFAAs have been detected in protein-rich compartments, including blood serum, liver, and egg samples Gebbink et al., 2009; Houde et al., 2011) . The two commonly detected and most studied PFAAs are perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA); however, PFOS, PFOA, and their precursors have been voluntarily phased out of production by major manufacturers due to concerns about their potential toxicity to wildlife and humans (Martin et al., 2010) . Short-chain PFAAs are currently being manufactured and used as PFOS and PFOA substitutes due to their similar water-, oil-, and stain-resistant properties (Buck et al., 2011) .
Perfluorohexane sulfonate (PFHxS) and perfluorohexanoate (PFHxA) are two short-chain PFAAs for which avian biomonitoring and toxicological data are limited. PFHxS was detected in the blood of female herring gulls collected from Chantry Island, Lake Huron, with the highest proportion observed in plasma . PFHxS was also detected in liver of numerous avian species worldwide including gray herons, herring gulls, Eurasian sparrow hawks, magpies, and collared doves; concentrations ranged from < 3.2 to 120.7 ng PFHxS/g wet weight (ww) (Houde et al., 2011; Kannan et al., 2002; Meyer et al., 2009) . In herring gull colonies from the Great Lakes, PFHxS concentrations ranged from below detection limits to 3.8 ng/g ww in whole eggs . PFHxA concentrations in avian samples are typically at or below the detection limit (Karrman et al., 2010; Verreault et al., 2005) ; however, it has been detected in waterbird eggs from Hong Kong (< 0.01-0.071 ng/g ww) and herring gulls from Lake Huron Wang et al., 2008) .
There is some evidence to suggest that PFAAs can impact essential endocrine pathways and neurodevelopment in birds and other animals. In a study by Vongphachan et al. (2011) , PFHxS and PFHxA altered the messenger RNA (mRNA) expression of thyroid hormone (TH)-responsive transcripts in chicken embryonic neuronal (CEN) cells. PFHxS induced the expression of type III 5#-deiodinase (D3) and neurogranin (RC3) and reduced the expression of transthyretin. PFHxA induced type II 5#-deiodinase (D2), D3, and myelin basic protein mRNA levels. TH disruption effects were also observed in response to PFOS and PFOA treatment in mammalian models; PFOS and PFOA altered TH levels and hampered brain development in rodents (Johansson et al., 2008 (Johansson et al., , 2009 Lau et al., 2003; Thibodeaux et al., 2003; Yu et al., 2009) . Central nervous system development is TH dependent, and altered thyroid status during development could result in serious, permanent effects on central nervous system function. Chicken egg injection studies reported reduced hatching success in response to PFOS and PFOA, which may be a consequence of poor motor skills associated with altered brain development, as well as higher incidences of physical deformities (Molina et al., 2006; O'Brien et al., 2009a,b; Yanai et al., 2008) . Posthatch cognitive behavior (i.e., imprinting behavior), immune alterations, and brain asymmetry changes have also been observed following in ovo PFOS and PFOA exposure (Peden-Adams et al., 2009; Pinkas et al., 2010) . The importance of studying the effects of PFAAs on avian endocrine systems and neurodevelopment is evident.
The present study determined the effects of in ovo PFHxS and PFHxA exposure on developing chicken embryos. The main objectives of this study were to (1) determine pipping success over a large range of doses; (2) assess the impacts on growth and development; (3) measure the tissue-specific accumulation in yolk sac, liver, and cerebral cortex; (4) determine the mRNA expression of TH-dependent transcripts and compare these findings with in vitro studies (hepatocytes and neuronal cells); and (5) evaluate the effects on circulating free thyroxine (T4) levels. THs play an essential role in avian development (i.e., metabolism, growth, and differentiation/ maturation) (McNabb, 2007) , and the possible disruption of the TH neuroendocrine system via PFAA exposure during development may result in irreversible effects that are harmful to avian species.
MATERIALS AND METHODS
Chemicals. Linear sodium perfluorohexane sulfonate (PFHxS) and linear sodium perfluorohexanoate (PFHxA) were purchased from Wellington Laboratories (Guelph, Ontario; > 98% pure). All stock solutions and serial dilutions were prepared in dimethyl sulfoxide (DMSO; Fisher Scientific, Ottawa, Ontario) to yield actual, final injection concentrations ranging from 8.9 to 38,000 ng PFHxS/g egg and 9.7 to 9700 ng PFHxA/g egg. The maximal dose assessed in the PFHxA egg injection experiment is lower than that of PFHxS due to insufficient quantities of the compound. The concentrations of the solutions injected into the eggs were determined by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) in negative electrospray mode, as described below.
PFHxS and PFHxA standard solutions (50 lg/ml in methanol) for HPLC-MS/MS analysis and the appropriate internal standards, sodium perfluoro-1-hexane[
18
O 2 ]sulfonate (MPFHxS) and perfluoro-n- [1, 2, 3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]hexanoate (MPFHxA) (50 lg/ml in methanol), were purchased from Wellington Laboratories. Working solutions of the analytes and internal standards were prepared from stock solutions by several dilutions with methanol. Ammonium hydroxide (28-30%) and formic acid (98-100%) were American Chemical Society reagent grade and purchased from VWR (Mississauga, Ontario). Ammonium acetate (99.9%) was purchased from Sigma-Aldrich (Oakville, Ontario). HPLC-grade methanol and acetonitrile were purchased from Fisher Scientific.
Egg injection and tissue collection. Two separate egg injection experiments were performed to assess the effects of PFHxS and PFHxA on pipping success, embryonic development, tissue accumulation, hepatic and neuronal mRNA expression, and plasma-free T4 concentrations. A total of 220 unincubated, fertilized White Leghorn chicken (Gallus gallus domesticus) eggs were obtained from the Canadian Food Inspection Agency (Ottawa, Ontario). All procedures involving the handling of animals were conducted according to protocols approved by the Animal Care Committee at the National Wildlife Research Centre.
One hundred and twenty eggs were randomly distributed into a control group and five treatment groups for the PFHxS egg injection study. Egg injections were performed as previously described (Crump et al., 2010) . In brief, a small hole was drilled through the egg shell at the center of the air cell, and based on the average mass of the eggs (~50 g per egg), the same volume of DMSO or PFAA (~1 ll/g egg) was injected into the air cell to attain the desired concentrations described above. After injection, the hole was sealed with AirPore Tape (Qiagen, Mississauga, Ontario) and eggs were then placed horizontally into an incubator (Petersime, Model XI) set at 37.5°C and 58% humidity. During incubation, embryos were monitored frequently by candling and brought to pipping (days 21-22, stage 46) (Hamilton and Hamburger, 1951) . Infertile and dead embryos were removed, and the developmental stage was determined for dead embryos (data not shown). Pipping success was determined by dividing the number of embryos that pipped by day 22 by the number of total fertile eggs per treatment group. Embryos that did not make a pipping star by day 22 were considered unfit to hatch.
Embryos that pipped successfully were euthanized by decapitation, and embryo, yolk sac, liver and cerebral cortex weights, tarsus length, and time to pip were recorded. Significant differences in tarsus length, embryo/tissue weight, and time to pip among dose groups were determined using a one-way ANOVA followed by a Bonferroni's t-test for multiple comparisons versus the vehicle control (SigmaStat v2.03; SPSS). Changes were considered statistically significant if p < 0.05.
The entire yolk sac and portions of the liver (left lobe) and cerebral cortex (left hemisphere) were collected from six to eight embryos per treatment group and stored at À20°C. Yolk sacs and subsamples of liver and cerebral cortices were pooled (six to eight per treatment group) for subsequent chemical analysis of PFHxS and PFHxA concentrations. The right lobe of the liver and the right hemisphere of the cerebral cortex were immediately frozen in liquid nitrogen and stored at À80°C for subsequent RNA isolation. Blood samples PFHXS AND PFHXA EFFECTS IN CHICKEN EMBRYOS 217 (~0.2-1 ml) were collected from each embryo and mixed with 10 ll of a heparin solution (0.2 mg/ml in sterile water) to prevent coagulation. Blood samples were kept on ice and then spun at 20,800 3 g for 5 min to separate plasma and red blood cells. Plasma was stored at À80°C for subsequent free T4 concentration determination.
Determination of PFHxS and PFHxA. PFHxS and PFHxA analysis was performed using a previously described method with modifications. In brief, tissue samples (0.1-0.2 g) were cleaned on Oasis weak anion exchange solid phase extraction (WAX SPE) cartridges (3 ml, 60 mg) purchased from Waters (Mississauga, Ontario) and spiked with 100 ll of an internal standard solution containing 1000 ng/ml of MPFHxS or MPFHxA prior to extraction. For PFHxS and PFHxA detection, a Waters Alliance 2695 HPLC system coupled to a Micromass Quattro Ultima triple quadrupole mass spectrometer equipped with an electrospray ionization interface was used. Analytes were separated chromatographically on an ACE 3 C 18 column (50 mm l 3 2.1 mm inner diameter, 3 lm particle size). The mobile phases were water (A) and methanol (B), both containing equal concentrations of 2mM ammonium acetate. The elution gradient was as follows: initial mix of 95% mobile phase A and 5% mobile phase B, increasing to 100% mobile phase B within 6 min and held for 4 min, and then decreasing to 5% mobile phase B within 1 min and held for 4 min. The MS/MS was operated in negative ion mode with multiple reaction monitoring.
Quantitative analysis was performed by the isotope dilution method. MPFHxS and MPFHxA were used as internal standards for PFHxS and PFHxA, respectively. A weighted (1/concentration) linear regression mode was selected on MassLynx (v 4.0) instrument software for fitting of the calibration curve. The method detection limit (MDL) value was measured by performing replicate analyses (n ¼ 8) of 1 g pork liver samples, which were spiked with analytes at a concentration three to five times the estimated detection limit and calculating the standard deviation. The limit of detection (LOD) was estimated based on a ratio, peak to peak, of 3 between the signal of the analyte and the baseline noise. The MDL was 0.1 ng/g for PFHxS and PFHxA, whereas the LOD was 0.2 and 0.1 ng/g for PFHxS and PFHxA, respectively. Linear regression analyses were performed to compare PFHxS and PFHxA concentrations in yolk sac, liver, and cerebral cortex with the actual injection concentrations (based on the pool of six to eight samples per treatment group).
RNA isolation and complementary DNA (cDNA) synthesis. Total RNA was isolated from a 20-to 30-mg portion of the right liver lobe and the right cerebral cortex (n ¼ 6-8 per treatment group) using the RNeasy mini kit according to the manufacturer's instructions (Qiagen). The concentration and purity of extracted RNA was quantified by determining the A260/A280 absorbance ratio on a NanoDrop 2000 spectrophotometer (Thermo Scientific, Wilmington, DE). All samples used for real-time reverse transcription-PCR (RT-PCR) analysis had an A260/A280 ratio between 1.9 and 2.1. Approximately 500 ng of total RNA was DNase treated using DNA-free kits according to the manufacturer (Ambion, Austin, TX) and used for cDNA synthesis. RNA was reverse transcribed to cDNA using SuperScript II and random hexamer primers as described by the manufacturer (Invitrogen, Burlington, Ontario). Reactions containing an RNA template but lacking reverse transcriptase were run in parallel to verify the absence of contaminating genomic DNA (noreverse transcriptase control). A 1:10 dilution of cDNA with diethylpyrocarbonate (DEPC)-treated water was prepared and stored at À80°C for subsequent real-time RT-PCR.
Real-time RT-PCR. Changes in mRNA expression were assessed by realtime RT-PCR using the Brilliant Q-PCR Core Reagent kit and MX3000P or MX3005P PCR systems (Stratagene, La Jolla, CA). Primer pairs (Invitrogen) and TaqMan fluorogenic probes (Biosearch, Novato, CA) for the transcripts listed in Table 1 were designed and optimized for real-time RT-PCR as previously described.
Each 25-ll reaction contained 13 Core PCR buffer, 5mM MgCl 2 , 0.8mM deoxynucleotide triphosphate mix, 8% glycerol, 75nM ROX reference dye, forward and reverse primers at concentrations previously optimized, 200nM fluorogenic probe, 5 ll diluted cDNA (1:10), and 1.25 U SureStart Taq Polymerase. The thermocycle program included an enzyme activation step at 95°C (10 min) and 40 cycles of 95°C (30 s) and 60°C (1 min). All reactions were performed using cDNA from four to eight individual embryos per treatment group run in duplicate for each assay. All gene targets were normalized to b-actin as its expression was invariable across treatment groups (internal control). An identical reaction was conducted, in parallel, for each assay by replacing cDNA template with DEPC water (no template control) to monitor for contamination. Cycle threshold (Ct) data were normalized to b-actin, and the fold change in target gene mRNA abundance in PFAA treatment groups compared with the vehicle control was calculated using the 2 ÀDCt equation (Schmittgen and Livak, 2008) . Statistically significant differences in mRNA expression were identified by performing a one-way ANOVA to 2 ÀDCt -transformed data followed by a Bonferroni's t-test for multiple comparisons versus the vehicle control (SigmaStat v2.03; SPSS). Changes were considered statistically significant if p < 0.05.
Free T4 determination. Free T4 levels were determined in plasma collected from chicken embryos following PFHxS and PFHxA exposure using the AccuBind Free T4 kit (Monobind Inc., Lake Forest, CA) as per the manufacturer's instructions. The dose groups assessed were as follows: DMSO control (n ¼ 22 selected randomly from the two studies), 8.9 (n ¼ 6), 890 (n ¼ 12), and 38,000 ng PFHxS/g (n ¼ 11); and 9.7 (n ¼ 10), 1000 (n ¼ 11), and 9700 ng PFHxA/g (n ¼ 8). The kit is based on the competition among an immobilized antibody, an enzyme-antigen conjugate, and free T4 in a 96-well microplate. In brief, standards, controls (human serum references 0.4 and 1.25 ng/dl, Randox Laboratories Ltd, Antrim, U.K.), and samples were added to the microplate, and when equilibration was reached, the unbound antigen fraction was removed and the enzyme activity in the bound fraction was measured at 450 nm on a SpectraMax 190 UV-VIS microplate reader (Molecular Devices, Sunnyvale, CA). Enzyme activity is inversely proportional to the concentration of free T4 in the sample. Concentration values (ng/dl) were determined from the standard curve, which was fitted using a variable slope (four parameter) method in Prism software (GraphPad, La Jolla, CA). The LOD was 0.05 ng/dl; values equal or less than this were assigned a value of half the detection limit (i.e., 0.025 ng/dl). A one-way ANOVA followed by Tukey's post hoc test was used to determine significant differences in free T4 concentrations among the dose groups (p < 0.05).
RESULTS

Pipping Success
PFHxS decreased pipping success of the domestic chicken to 63% in embryos exposed to the highest dose group of 38,000 ng/g (Table 2 ). In the PFHxA egg injection study, pipping success was 80% in embryos exposed to the highest dose group of 9700 ng/g ( Table 2 ). The percent pipping success for all PFHxA-exposed embryos fell within the range observed in previous studies for DMSO-injected eggs (80-100%) O'Brien et al., 2009a,b) ; however, the highest dose group for PFHxS did not. Average time to pip did not significantly change (p > 0.05) in either of the egg injection studies (data not shown).
Embryonic Development
Of the morphometric parameters assessed in this study, tarsus length and embryo mass were affected by PFHxS exposure. Relative to the DMSO control, average tarsus length (27.1 vs. 25.2 mm) and embryo mass (30.4 vs. 27.1 g) were significantly (p < 0.05) decreased at the highest dose of PFHxS (38,000 ng/g; Figs. 1A and 1B). Liver weight was not significantly different among groups (p > 0.05; data not shown). None of the morphometric parameters were significantly (p > 0.05) affected in PFHxA-exposed embryos (data not shown).
PFHxS and PFHxA Concentrations in Yolk Sac, Liver, and Cerebral Cortex
Significant linear correlations (r 2 ¼ 0.99; p < 0.0001 for all correlations) were observed between PFHxS dose group and concentration in yolk sac (y ¼ 7.8x À 1997), liver (y ¼ 4.5x À 742), and cerebral cortex (y ¼ 0.59x À 275). These relationships demonstrate dose-dependent accumulation; however, the extent of uptake was variable between yolk sac, liver, and cerebral cortex. PFHxS preferentially accumulated in the yolk sac > liver > cerebral cortex, with the exception of the 9 ng/g dose group, where liver > yolk sac > cerebral cortex. Enrichment of PFHxS in yolk sac and liver was evident as the measured concentrations exceeded their respective actual whole-egg injection concentrations. For example, in the 38,000 ng/g dose group, concentrations of 300,000, and 170,000 ng/g were reported in yolk sac and liver, respectively (Table 2) . Note. Tissues were harvested and pooled (n ¼ 6-8), and PFAA concentrations were measured by HPLC-MS/MS. stock concentrations (mg/ml) and injection concentrations (ng/g) are also included. Pipping success is reported as a ratio (no. of embryos that pipped/no. of total fertile embryos) and a percentage (%).
FIG. 1. Morphometric effects of in ovo
PFHxS exposure were observed for the following embryonic developmental parameters in chickens: (A) tarsus length (mm) and (B) embryo mass (g). Measurements were taken for all viable embryos at pipping, and error bars represent the SEM (n ¼ 16-20; *p < 0.05).
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Likewise, significant linear correlations (r 2 ¼ 0.99; p < 0.0001 for all correlations) were observed between PFHxA dose group and concentration in yolk sac (y ¼ 4.5x À 404), liver (y ¼ 3.1x À 107), and cerebral cortex (y ¼ 0.83x À 0.69). Concentrations of PFHxA increased in a dose-dependent manner in yolk sac, liver, and cerebral cortex to a maximum of 43,000, 30,000, and 800 ng/g, in the 9700 ng/g dose group, respectively (Table 2) . Similar to PFHxS, PFHxA preferentially accumulated in the yolk sac > liver > cerebral cortex, and enrichment was observed in yolk sac and liver as levels exceeded the actual whole-egg injection concentrations.
Hepatic and Neuronal mRNA Expression
Hepatic mRNA expression of two TH-responsive genes, D2 and D3, was upregulated in liver tissue of embryos exposed to PFHxS. D2 mRNA increased fivefold at doses of 9300 and 38,000 ng/g (p < 0.001), whereas D3 mRNA expression increased sixfold or greater at doses ! 890 ng/g (p < 0.05 for 890 ng/g dose group; Fig. 2A ). The mRNA of the phase I metabolizing enzyme, cytochrome P450 3A37 (CYP3A37), was also induced fourfold following exposure to 38,000 ng/g PFHxS in the liver (p < 0.05; Fig. 2A ). Neuronal mRNA expression levels of D2 and two other TH-responsive genes, RC3 and octamer motif binding factor 1 (OCT1), were induced by PFHxS in chicken embryos. The D2, RC3, and OCT1 mRNA levels were significantly upregulated by four-, six-, and threefold, respectively, at concentrations ! 9300 ng/g (p < 0.001; Fig. 2B ). None of the mRNA transcripts assessed were significantly affected in PFHxA-exposed chicken embryos (p > 0.05, data not shown).
Free T4 Determination
Free T4 concentrations were significantly reduced in plasma collected from chicken embryos exposed to 890 (p < 0.05) and 38,000 ng PFHxS/g (p < 0.001) compared with the DMSO control, whereas the lowest dose of 8.9 ng/g did not have a significant effect on free T4 levels (p > 0.05; Fig. 3A) . No significant effects on free T4 levels were observed following exposure to any of the PFHxA concentrations assessed (p > 0.05; Fig. 3B ).
DISCUSSION
This study determined the effects of PFHxS and PFHxA on embryonic lethality, developmental endpoints, tissue-specific accumulation, hepatic and neuronal mRNA expression, and
The relative mRNA expression levels of hepatic and neuronal genes following in ovo exposure of chicken embryos to PFHxS. mRNA levels of (A) D2, D3, and CYP3A37 in liver tissue and (B) D2, RC3, and OCT1 in cerebral cortex tissue in response to PFHxS were determined by real-time RT-PCR (n ¼ 4-8; error bars represent SEM; *p < 0.05; **p < 0.001).
FIG. 3.
T4 levels (ng/ml) were determined in plasma of embryos exposed to (A) PFHxS and (B) PFHxA relative to the DMSO control using the AccuBind free T4 kit. Error bars represent the SEM (n ¼ 8-22, *p < 0.05, **p < 0.001). 220 CASSONE ET AL. free T4 levels in chicken embryos. Given the chemical stability and persistence of PFAAs in the environment; their accumulation in blood serum, liver tissue, and eggs of wild avian species; and the potential of this class of compounds to disrupt the TH pathway, the importance of determining the effects of PFHxS and PFHxA in an avian species is apparent.
Limited toxicity data exist for PFHxS and PFHxA and those that are available are from chronic, subchronic, and acute mammalian studies (Butenhoff et al., 2009; Chengelis et al., 2009; Loveless et al., 2009) ; none are based on avian studies. In this study, embryo pipping success was decreased to 63% in the 38,000 ng PFHxS/g dose group (compared with 94% in the DMSO control). In the highest PFHxA dose group, 9700 ng/g, pipping success was 80% (compared with 89% in the DMSO control). Variability in pipping success among DMSO and untreated control groups (80-100%) was observed in previous chicken egg injection studies O'Brien et al., 2009a,b) . Therefore, PFHxA was not considered lethal to embryos at the doses assessed because the lowest value fell within the range expected for control groups. PFHxS, on the other hand, caused a decrease in pipping success below this range and was lethal to embryos at an injected concentration of 38,000 ng/g. This injected concentration yielded hepatic levels of 170,000 ng/g ww, which is more than three orders of magnitude greater than the maximum reported mean PFHxS concentration in wild avian tissues; 50 ng/g ww in liver tissue of gray herons (Meyer et al., 2009) . The highest concentration of PFHxA administered, 9700 ng/g, was more than five orders of magnitude greater than that detected in waterbird eggs; 0.071 ng/g ww in great egrets (Wang et al., 2008) .
In addition to decreasing pipping success, exposure to 38,000 ng PFHxS/g altered embryonic growth. Mean tarsus length and embryo mass were significantly decreased relative to the DMSO control group. On the other hand, exposure up to the highest dose of 9700 ng PFHxA/g did not affect any of the growth parameters assessed in this study. Overall, PFHxS was found to alter pipping success and growth/development of embryonic chickens injected prior to incubation. Given the importance of the TH pathway in mediating growth and development in avian species, these findings support further evaluation of TH disruption.
In this study, PFHxS and PFHxA preferentially accumulated in yolk sac > liver > cerebral cortex. Concentrations in yolk sac and liver exceeded the whole-egg injection concentration and resulted in maximal enrichment factors (tissue concentration/injected concentration) of 7.8 and 4.5 for PFHxS and 4.4 and 3 for PFHxA. In cerebral cortex, levels were consistently lower than the initial injection concentration. The accumulation of PFAAs in hepatic tissue above initial whole-egg concentrations was observed in chicken egg injection studies with PFOS, PFOA, perfluoroundecanoic acid, and perfluorodecane sulfonate in which maximum enrichment factors of 1.5-4.5 were reported (O'Brien et al., 2009a,b) .
PFAAs are generally highly acidic and exist in aqueous environments as their conjugate bases. Furthermore, the fluorinated hydrocarbon tail of the PFAA conjugate base is lipophilic, and the carboxylate or sulfonate functional group is hydrophilic. The polar end of PFAAs preferentially binds with proteins-specifically fatty acid-binding proteins, lipoproteins, and albumin. PFAAs are sequestered into protein-rich tissues, such as yolk, liver, and blood (Jones et al., 2003; Luebker et al., 2002) . Our findings of maximal PFHxS and PFHxA levels in protein-rich compartments (i.e., yolk sac and liver) are consistent with preferential sequestration into protein-rich tissues. The detection of PFHxS and PFHxA in the cerebral cortex of chicken embryos demonstrates that they are able to cross the blood-brain barrier. PFOS has also been detected in the brain following laboratory exposures (Austin et al., 2003; Sato et al., 2009) . A dose-dependent accumulation of PFOS was reported in adult female rats ip injected with PFOS at 1 mg/kg body weight (BW) (low dose) and 10 mg/kg BW (high dose) in all brain regions measured (i.e., hypothalamus, cerebral cortex, hippocampus, brain stem, and cerebellum). For instance, in cerebral cortex tissue, the low-dose group accumulated 294 ng PFOS/g ww, whereas the high-dose group accumulated 4487 ng PFOS/g ww. These concentrations are comparable to those observed in the present study. Concentrations of 490 and 3800 ng PFHxS/g ww were detected in the cerebral cortex from the 890 and 9300 ng PFHxS/g dose groups, respectively. PFHxA accumulation was also observed in the cerebral cortex, however, to a lesser extent. At the two highest PFHxA dose groups (1000 and 9700 ng/g), PFHxA accumulated to 70 and 800 ng PFHxA/g ww, respectively.
In addition to the overt effects on embryonic development, it was important to assess effects at a more subtle level, i.e., to identify molecular/biochemical effects of exposure that could be linked to the observed response. One of the objectives of this study was to determine the effects of PFHxS and PFHxA treatment on relative mRNA expression levels of several THresponsive genes in the liver and cerebral cortex of chicken embryos. The molecular mechanisms of action of PFAAs remain unclear, although in recent years the TH pathway has become an evident target (Cheng et al., 2011; Lau et al., 2003; Thibodeaux et al., 2003; Vongphachan et al., 2011; Weiss et al., 2009; Yu et al., 2009) .
The mRNA expression levels of a phase I xenobioticmetabolizing enzyme, CYP3A37, were induced in response to PFHxS in the liver by fourfold. CYP3A37 is a chicken xenobiotic-sensing orphan nuclear receptor-regulated enzyme and its upregulation is associated with increased biotransformation of xenobiotics for detoxication (Goriya et al., 2005) . The mRNA expression levels of two enzymes involved in TH homeostasis, D2 and D3, were significantly altered in liver tissue exposed to PFHxS. D2, which converts T4 to its more active form triiodothyronine (T3), was significantly upregulated in liver tissue of PFHxS-exposed embryos by fivefold. D3 degrades T4 and/or T3 to form inactive TH derivatives and was PFHXS AND PFHXA EFFECTS IN CHICKEN EMBRYOS 221 also significantly induced in PFHxS-exposed liver tissue by ninefold, with maximal induction levels greater than those observed for D2 in the liver. Increased D2 and D3 mRNA expression within the liver could lead to altered protein expression and deiodination (outside the scope of the current study) and may be the result of a depletion in circulating T4 levels as T4 would be taken up from the blood stream and into the liver for local deiodination. Future studies would benefit from measuring T4 levels in target tissues (e.g., liver, thyroid gland, and cerebral cortex) to help determine the cause and effect relationship between reduced T4 levels and altered deiodinase expression. Reduced TH levels can impact overall growth, development, and reproduction of birds.
In the cerebral cortex of chicken embryos exposed to PFHxS, TH-responsive genes that were affected included D2, RC3, and OCT1. D2 was induced by PFHxS exposure by fourfold. Increases in D2 levels in cerebral cortex could also lead to diminished circulating T4 levels as a result of augmented, localized outer ring deiodination of available T4. RC3 is a calmodulin-binding protein kinase C substrate that is under specific regional and temporal control by T3 (Morte et al., 1997) . For example, T3 administration increased RC3 mRNA expression up to 30-fold in hypothyroid rats (Iniguez et al., 1993) . RC3 was upregulated sixfold in cerebral cortex tissue in response to PFHxS treatment, a response similar to that observed in CEN cells (i.e., 11-fold induction at 10lM PFHxS) (Vongphachan et al., 2011) . Moreover, a commercial mixture of polychlorinated biphenyls (Aroclor 1254)-a class of compounds also suspected of disrupting TH homeostasisinduced RC3 expression in the cerebral cortex of fetal rats demonstrating that RC3 was responsive to an environmental contaminant and that Aroclor 1254 was able to exert TH-like effects via alteration of TH-responsive genes (Gauger et al., 2004) . Changes in RC3 may also have biological implications in synaptic plasticity, associative learning, and memory (Iniguez et al., 1996) . OCT1 is a transcription factor involved in cell proliferation, and reduced expression is associated with cell cycle arrest and reduced morphological differentiation (Lakin et al., 1995) . OCT1 expression is responsive to thyroid status-a single dose of T4 increased OCT1 levels in the cortex of athyroid rat pups exposed through the mother during gestation (Dowling et al., 2000) . In addition, OCT1 has been shown to stimulate thyroid receptor b1 (TRb1) in cortical neurons, and it was suggested that TH may act through TRb1 to enhance OCT1 expression (Nagasawa et al., 1997) . OCT1 expression was induced threefold in response to PFHxS treatment in this study. Furthermore, OCT1 was upregulated three-and fivefold in herring gull embryonic neuronal cells by PFHxS and PFHxA, respectively (Vongphachan et al., 2011) . OCT1 is also responsive to other environmental contaminants. For example, Aroclor 1254 induced OCT1 expression in the cortex of rodents (Gauger et al., 2004) . The concordance between the present in ovo study and the in vitro study by Vongphachan et al., (2011) strongly implies that the TH axis is affected by PFAA action.
The observed effects on growth and development combined with the molecular data presented in this study indicate that the TH pathway is a target of PFHxS action. To further support TH disruption effects, we determined free T4 levels in the plasma of developing chicken embryos exposed to PFHxS and PFHxA. PFHxS significantly decreased plasma free T4 levels in a dose-dependent manner, whereas PFHxA had no effect on circulating hormone concentration. The depleted free T4 status observed in PFHxS-exposed embryos is in agreement with several of the altered endpoints presented in this study (i.e., reduced pipping success, embryo growth, and increased deiodinase expression). The TH axis and the growth hormone (GH) axis are closely related, and cross talk interactions exist between them. GH is required for normal somatic growth in the pre-and posthatch chicken, and there is a critical range of TH levels required for growth; concentrations above or below this range lead to decreased growth (McNabb, 2007) . Future studies would benefit from a detailed assessment of the cross talk between the TH and the GH axes in avian species as it pertains to altered somatic growth following exposure to environmental contaminants.
The adverse effects in response to PFHxS exposure reported in the present study may, in part, represent a component of an adverse outcome pathway (AOP). An AOP is defined as a sequential series of events that span multiple levels of biological organization used for predictive ecological risk assessment (Ankley et al., 2010) . PFHxS affected the TH pathway at multiple levels of biological organization-somatic growth, mRNA expression, and circulating free T4 concentrations. The lowest PFHxS concentration for which an effect in mRNA expression and circulating free T4 levels was observed was 890 ng/g (injected concentration) or 5100 ng/g ww (liver concentration). These concentrations are 18 or 100 times greater, respectively, than the highest reported mean PFHxS concentration in avian wildlife (50 ng/g ww in liver of gray herons; Meyer et al., 2009) . TH responses and pathways may be useful in predicting the toxicity of other chemicals in future risk assessments in avian species. 
